CIMT Working Groups

The association for Cancer Immunotherapy is encouraging its members to initiate working groups that address the urgent needs in the field.

For this reason the CIMT Immunoguiding Program (CIP) and the CIMT Regulatory Research Group (RRG) were founded. From the development of research programs to influencing legislative processes CIMT is acting jointly to facilitate and foster the invention and clinical translation of innovative cancer immunotherapies.